Australia markets open in 3 hours 40 minutes

Kraig Biocraft Laboratories, Inc. (KBLB)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0385-0.0010 (-2.53%)
As of 01:52PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.0395
Open0.0390
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0375 - 0.0400
52-week range0.0300 - 0.1000
Volume830,640
Avg. volume875,844
Market cap39.462M
Beta (5Y monthly)0.25
PE ratio (TTM)N/A
EPS (TTM)-0.0090
Earnings date14 Mar 2023 - 20 Mar 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Kraig Biocraft Laboratories Delivers the First Two Hybrid Dragon Silk™ Silkworm Strains for Commercial Production

    ANN ARBOR, Mich., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercialization of spider silk, announces that it has delivered the first two hybrid-cross Dragon Silk™ strains to its third-party production partner in Vietnam. These strains were developed to address the most significant immediate hurdle to large-scale production, the robustness of our silkworms within the la

  • GlobeNewswire

    Kraig Biocraft Laboratories Completes Closeout of $8 Million Financing, Extinguishing All Convertible Debentures with Yorkville Advisors

    ANN ARBOR, Mich., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercialization of spider silk, announces that it has completed the debt-to-equity conversion on $8 million of convertible debentures with Yorkville Advisors. This closeout comes several months ahead of schedule and positions the Company to enter 2023 without any convertible debt obligations to Yorkville Adviso

  • GlobeNewswire

    Kraig Biocraft Laboratories poised to Close Out Yorkville Convertible Debenture with Strongest Financial Position in Corporate History

    ANN ARBOR, Mich., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), the biotechnology company focused on the development and commercialization of spider silk, announces that it has nearly closed out its $8 million in convertible debenture with Yorkville Advisors. Over the last 23 months, the Company has converted more than 98% of this debt to equity. Kraig Labs remains in one of the strongest financial positions in the Company's hi